Unique Diagnostics Private Limited - Due diligence report

A 360° intelligence report on Unique Diagnostics: trust score, financial health, credit view, compliance, directors, growth and distress sig…

1986-03-07 New Delhi, Delhi Active Unlisted Active Compliant
Share
View plans Plan
UD Unique Diagnostics Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Unique Diagnostics — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Unique Diagnostics is assessed as Low Risk with a Trust Score of 86/100. Unique Diagnostics is an active private limited indian non-government company incorporated in 1986, operating in the Healthcare sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 09 Jul 2026 from the latest processed filings. Unique Diagnostics Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
DIGENDRA SINGH 01234567 Director 01/04/2018 6 yrs Approved
ROMIL JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • DIGENDRA SINGH has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 90
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Operating for 40+ years.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence93/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
29 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
06 Aug 2018
Director ceased
DIGENDRA SINGH
25 May 2018
Director ceased
SURESH KUMAR MOHANTY
23 May 2018
Director appointed
DIGENDRA SINGH (Director)
30 Sep 2014
Director ceased
ROMIL JAIN
18 Jul 2014
Director ceased
VANDANA JAIN
Director ceased
DEEPAK KUMAR SINGH
Director ceased
PANKAJ KUMAR SHARMA
28 Jun 2014
Director appointed
ROMIL JAIN (Director)
24 Sep 2013
Director ceased
CHANDER PAL SINGH
05 Jul 2010
Director ceased
MOHIT GUPTA
22 Apr 2008
Director ceased
DHARMENDRA KUMAR JAIN
Director ceased
RAJESH KUMAR
07 Mar 1986
Incorporated
Registered with Roc Delhi I
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Kelpways Labs Private Limited U74120UP2013PTC054691 Lucknow, Uttar Pradesh, India
Shikum Pharmaceutical Private Limited U24233UP2013PTC055974 Sultanpur, Uttar Pradesh, India
Spiriit Nursing Private Limited U85320DL2018PTC340903 Shakar Pur, Delhi, India
Ulticure Biolabs Private Limited U51909DL2012PTC237931 Delhi, Delhi, India
Nallatesh Wellness Services Private Limited U85100MH2018PTC312115 Navi Mumbai, Maharashtra, India
Vedicus Healthcare Private Limited U85100HR2015PTC057582 Yamuna Nagar, Haryana, India
Anuseva Health Care Private Limited U85190TN2013PTC093927 Chennai, Tamil Nadu, India
Star Life Sciences Private Limited U24230TZ2012PTC018211 Hosur, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Unique Diagnostics before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Unique Diagnostics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Unique Diagnostics - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Unique Diagnostics pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Unique Diagnostics - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Unique Diagnostics an active company?

Unique Diagnostics has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Unique Diagnostics financially healthy?

Unique Diagnostics has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Unique Diagnostics?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Unique Diagnostics?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Unique Diagnostics have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Unique Diagnostics up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Unique Diagnostics?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.